The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders

The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders

Background: Gilles de la Tourette syndrome (TS) is a chronic neuropsychiatric disorder characterized by motor and vocal tics. First-line treatments for tics are antipsychotics and tic-specific behavioral therapies. However, due to a lack of trained therapists and adverse events of antipsychotic medi...

Full description

Bibliographic Details
Main Authors: Ewgeni Jakubovski, Anna Pisarenko, Carolin Fremer, Martina Haas, Marcus May, Carsten Schumacher, Christoph Schindler, Sebastian Häckl, Lukas Aguirre Davila, Armin Koch, Alexander Brunnauer, Camelia Lucia Cimpianu, Beat Lutz, Laura Bindila, Kirsten Müller-Vahl
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Psychiatry
Subjects:
cannabidiol
THC
tetrahydrocannabinol
cannabinoids
nabiximols
chronic tic disorder
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2020.575826/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2020.575826/full

Similar Items